What is Sinco Pharmaceutical Holdings Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sinco Pharmaceutical Holdings's Average Total Inventories for the quarter that ended in Jun. 2024 was HK$83 Mil. Sinco Pharmaceutical Holdings's Revenue for the
six
months ended in Jun. 2024 was HK$1,644 Mil.
Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.05.
Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Jun. 2024
increased
from Dec. 2023 (0.04) to Dec. 2023 (0.05)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Sinco Pharmaceutical Holdings's Days Inventory for the
six
months ended in Jun. 2024 was 10.38.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinco Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Jun. 2024 was 17.58.
Sinco Pharmaceutical Holdings Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sinco Pharmaceutical Holdings's Inventory-to-Revenue
For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinco Pharmaceutical Holdings's Inventory-to-Revenue Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Sinco Pharmaceutical Holdings's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Sinco Pharmaceutical Holdings's Days Inventory for the
six
months ended in Jun. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinco Pharmaceutical Holdings Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinco Pharmaceutical Holdings Business Description
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06833 has been successfully added to your 